IGFBP1(hi)WNT3A(lo) Subtype in Esophageal Cancer Predicts Response and Prolonged Survival with PD-(L)1 Inhibitor

SIMPLE SUMMARY: The lack of precision biomarkers hinders the development of individualized immunotherapy for esophageal cancer (ESCA) patients. The activation of WNT signaling has proved to be associated with the primary resistance to immunotherapy. Therefore, our study aims to develop efficient bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Meichen, Yan, Wanpu, Chen, Dongbo, Luo, Jiancheng, Dai, Liang, Chen, Hongsong, Chen, Ke-Neng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687176/
https://www.ncbi.nlm.nih.gov/pubmed/36358276
http://dx.doi.org/10.3390/biology11111575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687176/
https://www.ncbi.nlm.nih.gov/pubmed/36358276
http://dx.doi.org/10.3390/biology11111575

Ejemplares similares